One Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

One Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,541	Closed	-$24K	–	552
2022 Q4	$24K	Buy	+1,541	New	+$21.5K	0.01%	502

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

One Wealth Advisors's TAK Position: Q1 2023 in Review

One Wealth Advisors sold out of Takeda Pharmaceutical (TAK) in Q1 2023, closing a stake of 1,541 shares — an estimated $24K sold.

One Wealth Advisors first reported a position in TAK in Q4 2022 and held it in 1 quarter. The position peaked at $24K in Q4 2022. 300 funds tracked by Wall St. Rank hold TAK as of Q1 2023.

One Wealth Advisors reported no remaining Takeda Pharmaceutical position as of Q1 2023 after selling out during the quarter.
One Wealth Advisors sold 1,541 Takeda Pharmaceutical shares in Q1 2023, an estimated $24K.
One Wealth Advisors first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 1 quarter.
One Wealth Advisors's Takeda Pharmaceutical position peaked at $24K in Q4 2022.
300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2023.

Based on One Wealth Advisors's 13F filing for Q1 2023, filed 15 May 2023.